Proud to announce my review article on nebulisers in critical care has been published in JICS! - “Nebuliser therapy in critical care: The past, present and future” - journals.sagepub.com/doi/10.… @ICS_updates @ProfMalcolmSim @qeuhccm
Delighted to publish our pilot study protocol evaluating the use of nebulised normal saline for high secretions loads in mechanically ventilated patients! @PLOSONE @ProfMalcolmSim @dr_robhart @qeuhccm journals.plos.org/plosone/ar…
Great to present Hairmyres' new automated electronic M&M reporting system at #SICS23 @sicsmembers @wearehairmyres @hm_icu @NHSLanarkshire
Pleasure to write this article for @geekymedics overviewing the structure and function of the ANS! geekymedics.com/autonomic-ne… @Max_Ralston
Great to speak at the NHS Critical Care Summit today about nebuliser usage In ICU! @Convenzis_Group @Aerogen
Andrew Arnott retweeted
WE ARE LIVE!! 🗣️
Up next at the Critical Care conference is @Aerogen & Dr. Andrew Arnott from @NHSGGC!!
They'll discuss “Evidence-based use of nebulisers in the ICU:Lessons learned in the COVID pandemic””!!👏
Check out todays agenda... 👇
ow.ly/sXAT50JaR1F
Thanks to @GenomiccStudy for allowing me to train as an Associate PI. An educational and enjoyable experience that I would recommend to all that are interested in research! @NIHRresearch @steven1701
Great to see @DrGMcCreath present his findings on sepsis and secondary infection in COVID-19. Looking forward to seeing his metabolomic analysis soon! #ISICEM22
Delighted to have contributed towards the recruitment process for another GenOMICC success story! @GenomiccStudy @Nature
Out at 4pm today: our latest paper from GenOMICC reveals 16 new, robust genetic associations with critical Covid-19, some of which might lead directly to effective new treatments, just like our study in 2020 did. 1/n
nature.com/articles/s41586-0…
1
Andrew Arnott retweeted
The news just now from RECOVERY is another massive improvement in care of patients with Covid-19. It also has implications for how we treat, and study, other life-threatening disease. 1/n
Andrew Arnott retweeted
New publication in @TheLancetInfDis takes a critical look at the European clinical research response during the #covid_19 pandemic. Written by @ProfHGoossens, REMAP-CAP members @Lennie333 and @MarcBonten and @PeterHorby.
umcutrecht.nl/en/over-ons/ni…
A new @RECOVER_EUROPE publication! @ProfHGoossens, @Lennie333, @PeterHorby and
@MarcBonten published a paper on the lessons learned, the future perspective, and the recommendations linked to the European clinical research response during #COVID19 ➡️recover-europe.eu/press-rele…
Andrew Arnott retweeted
The Norman Exton-Smith prize for Best Scientific Poster Presentation goes to @drandrewarnott who looked at the utility of 24hr Ambulatory Blood Pressure Monitoring in patients with Orthostatic Hypotension at Syncope Clinic. 2/8
Andrew Arnott retweeted
So thrilled for our fabulous trainee @drandrewarnott winning the Norman Exton-Smith prize for best scientific poster at Autumn #bgsconf.
Looking at the utility of ambulatory BP monitoring in orthostatic hypotension. #research #juniordoctor #syncope #polypharnacy #design @GeriSoc – at Glasgow, Scotland














